Preclinical Targeting of TREM2 for the Treatment of Alzheimer's Disease-Type Pathology in a Transgenic Mouse Model

Brittani Rae Price
Alzheimer's disease (AD) is defined as a progressive neurodegenerative disorder and is characterized by a devastating mental decline. There are three pathological hallmarks of the disease necessary for its diagnosis, these are extracellular amyloid plaques comprised of the beta-amyloid (Aβ) protein, intracellular neurofibrillary tangles comprised of hyperphosphorylated tau protein, and marked neuronal loss. Active immunization against Aβ1-42 or passive immunization with monoclonal anti-Aβ antibodies has been shown to reduce amyloid deposition and improve cognition in...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.